Tumor Profiling in Endometrial Cancer
With our advanced Technologies for Tumor Profiling, Creative Biolabs has developed an unparalleled platform for endometrial tumor profiling. To fulfill every demand of our consumers, our professional scientists are ready to start working on your projects.
Introduction
Endometrial cancer (EC) is a prevalent gynecologic malignancy with high morbidity. A comprehensive endometrial tumor profiling could help explore the heterogeneity and interactions intra-tumor and in the tumor microenvironment (TME) of EC, as shown in Fig.1. Thus, endometrial tumor profiling is urgently needed for novel biomarker identification, prognostic and diagnostic analysis, and personalized immunotherapy.
Fig.1 Overview of human endometrial cancer heterogeneity. (Yu; et al, 2022)
Tumor Profiling in Endometrial Cancer at Creative Biolabs
Recent technological advances in tumor profiling area have provided us insight into the endometrial cancer heterogeneity. With industry-leading expertise and state-of-the-art single-use equipment, Creative Biolabs has pioneered endometrial tumor profiling.
-
List of some endometrial tumor profiling biomarkers:
Tumor profiling with tumor biomarkers could help support prognosis and precise treatment development, leading to future research improvement of brain cancer.
-
Workflow for endometrial tumor profiling
Features of Tumor Profiling in Endometrial Cancer at Creative Biolabs
-
Advanced technical platform with high sensitivity, accuracy, and repeatability
-
Rational programs with practiced expert teams
-
Fast Turnaround Time
Creative Biolabs is pleased to present world-leading tumor Profiling. For more details, please feel free to contact us directly.
Reference
-
Yu, Z.; et al. Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. Cell Proliferation. 2022, 55(6): e13249.
For Research Use Only | Not For Clinical Use